Canaccord analyst Maria Ripps raised the firm’s price target on Trupanion to $72 from $66 and keeps a Buy rating on the shares. The analyst said they reported solid Q4 results, with subscription enrolled pet growth, revenue, and adj. EBITDA all coming in ahead of expectations amid ongoing momentum within the vet channel.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TRUP:
- Trupanion reports Q4 EPS (23c), consensus (29c)
- Trupanion Reports Fourth Quarter and Full Year 2022 Results
- Trupanion to Present at the Bank of America Financial Services Conference
- Trupanion, Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
- Helping Pets Live Longer, Trupanion Surpasses Two Billion Dollars Paid Out to Veterinarians and Pet Parents